دورية أكاديمية

Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19

التفاصيل البيبلوغرافية
العنوان: Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19
المؤلفون: Jiaqi Huang, Yu Xu, Bin Wang, Ying Xiang, Na Wu, Wenjing Zhang, Tingting Xia, Zhiquan Yuan, Chengying Li, Xiaoyue Jia, Yifan Shan, Menglei Chen, Qi Li, Li Bai, Yafei Li
المصدر: BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-15 (2021)
بيانات النشر: BMC, 2021.
سنة النشر: 2021
المجموعة: LCC:Diseases of the respiratory system
مصطلحات موضوعية: COVID-19, Risk stratification score, Disease progression, Length of hospital stay, Diseases of the respiratory system, RC705-779
الوصف: Abstract Background During outbreak of Coronavirus Disease 2019 (COVID-19), healthcare providers are facing critical clinical decisions based on the prognosis of patients. Decision support tools of risk stratification are needed to predict outcomes in patients with different clinical types of COVID-19. Methods This retrospective cohort study recruited 2425 patients with moderate or severe COVID-19. A logistic regression model was used to select and estimate the factors independently associated with outcomes. Simplified risk stratification score systems were constructed to predict outcomes in moderate and severe patients with COVID-19, and their performances were evaluated by discrimination and calibration. Results We constructed two risk stratification score systems, named as STPCAL (including significant factors in the prediction model: number of clinical symptoms, the maximum body temperature during hospitalization, platelet count, C-reactive protein, albumin and lactate dehydrogenase) and TRPNCLP (including maximum body temperature during hospitalization, history of respiratory diseases, platelet count, neutrophil-to-lymphocyte ratio, creatinine, lactate dehydrogenase, and prothrombin time), to predict hospitalization duration for moderate patients and disease progression for severe patients, respectively. According to STPCAL score, moderate patients were classified into three risk categories for a longer hospital duration: low (Score 0–1, median = 8 days, with less than 20.0% probabilities), intermediate (Score 2–6, median = 13 days, with 30.0–78.9% probabilities), high (Score 7–9, median = 19 days, with more than 86.5% probabilities). Severe patients were stratified into three risk categories for disease progression: low risk (Score 0–5, with less than 12.7% probabilities), intermediate risk (Score 6–11, with 18.6–69.1% probabilities), and high risk (Score 12–16, with more than 77.9% probabilities) by TRPNCLP score. The two risk scores performed well with good discrimination and calibration. Conclusions Two easy-to-use risk stratification score systems were built to predict the outcomes in COVID-19 patients with different clinical types. Identifying high risk patients with longer stay or poor prognosis could assist healthcare providers in triaging patients when allocating limited healthcare during COVID-19 outbreak.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-2466
العلاقة: https://doaj.org/toc/1471-2466Test
DOI: 10.1186/s12890-021-01487-6
الوصول الحر: https://doaj.org/article/c9eb82dfa9e64ac085f8652da10ff2d1Test
رقم الانضمام: edsdoj.9eb82dfa9e64ac085f8652da10ff2d1
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14712466
DOI:10.1186/s12890-021-01487-6